Skip to content

Released Mar 12, 2026, after the close

10-K filed Mar 12, 2026, 71 days after period end · 0001636422-26-000035

Q4 2025 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$74.68Mderived−6.2% vs Q4 2024−2.2% vs Q3 2025
Net Income-$91.03MderivedN/M vs Q4 2024N/M vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$86,080,000N/M
Operating Cash Flowderived$9,912,000N/M
Free Cash Flowderived$9,639,000N/M
Margins · derived
Operating margin-115.3%−93.3 pt vs Q4 2024
Net margin-121.9%−95.9 pt vs Q4 2024

What the release said

The release

Same quarter

MetricQ4 2025derived from reported figuresQ4 2024derived from reported figuresQ4 2023derived from reported figuresQ4 2022derived from reported figures
Revenue$74.68M$79.61M$75.08M$69.16M
Net Income-$91.03M-$20.67M-$30.31M-$35.78M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR